Further, it has been shown that macrolide halichondramide (HCA) has an antimetastatic effect on human prostate cancer cells PC3, inhibiting their migration and invasion through the modulation of the crucial cadherin switches [141]. This evidence concerns the gene CDH17 and prostate carcinoma.